Because if they invest enough in marketing and regulatory compliance to keep it profitable, a generics manufacturer will immediately spin up and drink that milkshake.

If they abandon it, and no generic is produced, patients are forced to the patented alternatives.

The drug companies don't want to compete with their own products if they can avoid doing so.